Measuring continuous baseline covariate imbalances in clinical trial data

Statistical Methods in Medical Research

Volumn 24, Issue 2, 2015, Pages 255-272

  Ciolino, Jody D ^a   Martin, Reneé H ^a   Zhao, Wenle ^a   Hill, Michael D ^b   Jauch, Edward C ^c   Palesch, Yuko Y ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

baseline; clinical trial; covariate; imbalance

Indexed keywords

ANALYSIS OF COVARIANCE; ARTICLE; CLINICAL TRIAL (TOPIC); CONFIDENCE INTERVAL; CORRELATION COEFFICIENT; DATA PROCESSING; EXPLANATORY VARIABLE; HUMAN; HYPOTHESIS; PRACTICE GUIDELINE; SIMULATION; STATISTICAL MODEL; STATISTICAL PARAMETERS; STATISTICAL SIGNIFICANCE; STUDENT T TEST; AREA UNDER THE CURVE; BIOSTATISTICS; COMPUTER SIMULATION; MARKOV CHAIN; MULTIVARIATE ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL ANALYSIS; STATISTICAL BIAS; STATISTICS AND NUMERICAL DATA; STROKE;

TISSUE PLASMINOGEN ACTIVATOR;

AREA UNDER CURVE; BIAS (EPIDEMIOLOGY); BIOSTATISTICS; COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; HUMANS; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STOCHASTIC PROCESSES; STROKE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84928473255     PISSN: 09622802     EISSN: 14770334     Source Type: Journal    
DOI: 10.1177/0962280211416038     Document Type: Article

References (39)

1. Friedman LM, Furberg CD, DeMets DL Fundamentals of clinical trials. 2 nd edn. New York: Springer Science + Business Media, LLC, 1998. New York: Springer Science + Business Media, LLC ; 1998
2. Harrington DP. The randomized clinical trial. J Am Stat Assoc. 2000 ; 95: 312-315
3. Green S. Design of randomized trials. Epidemiol Rev. 2002 ; 24: 4-11
4. McEntegart DJ. The pursuit of balance using stratified and dynamic randomization techniques: An overview. Drug Inf J. 2005 ; 37: 293-308
5. Rosenberger WF, Lachin JM Randomization in clinical trials: Theory and practice. New York: Wiley Interscience ; 2002
6. Pocock SJ, Assmann SE, Enos LE, Kasten LE. Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: Current practice and problems. Stat Med. 2002 ; 21: 2917-2930
7. Austin PC, Manca A, Zwarenstein M, Juurlink DN, Stanbrook MB. A substantial and confusing variation exists in handling of baseline covariates in randomized controlled trials: A review of trials published in leading medical journals. J Clin Epidemiol. 2010 ; 63: 142-153
8. Altman DG. Comparabilty of randomised groups. Statistician. 1985 ; 34: 125-136
9. Senn SJ. Covariate imbalance and random allocation in clinical trials. Stat Med. 1989 ; 8: 467-475
10. Stigsby B, Taves D. Rank-minimization for balanced assignment of subjects in clinical trials. Contemp Clin Trials. 2010 ; 31: 147-150
11. Greevy R, Lu B, Silber JH, Rosenbaum P. Optimal multivariate matching before randomization. Biostatistics. 2004 ; 5: 263-275
12. Rosenbaum P, Rubin D. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Amer Stat. 1985 ; 39: 33-38
13. Begg CB, Iglewicz B. A treatment allocation procedure for sequential clinical trials. Biometrics. 1980 ; 36: 81-90
14. Atkinson AC. Optimum biased coin designs for sequential clinical trials with prognostic factors. Biometrika. 1982 ; 69: 61-67
15. Atkinson AC. The comparison of designs for sequential clinical trials with covariate information. J R Stat Soc A Sta. 2002 ; 165: 349-373
16. Gail MH, Weiand S, Piantadosi S. Biased estimates of treatment effect in randomized experiments with nonlinear regressions and omitted covariates. Biometrika. 1984 ; 71: 431-444
17. Robinson LD, Jewell NP. Some surprising results about covariate adjustment in logistic regression models. Int Stat Rev. 1991 ; 58: 227-240
18. Hauck WH, Andersone S, Marcus S. Should we adjust for covariates in nonlinear regression analyses of randomized trials?. Control Clin Trials. 1998 ; 19: 249-256
19. Hernandez AV, Steyerberg EW, Habbema JDF. Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements. J Clin Epidemiol. 2004 ; 57: 454-460
20. Hollander M, Wolfe DA Nonparametric statistical methods. 2 nd edn. New York: Wiley-Interscience, 1999. New York: Wiley-Interscience ; 1999
21. Ciolino JD, Zhao W, Martin RH, Palesch YY. Quantifying the cost in power of ignoring continuous baseline covariate imbalances in clinical trial randomization. Contemp Clin Trials. 2010 ;:
22. Huber M. Testing for covariate balance using nonparametric quantile regression and resampling methods. Unpublished Working and Discussion Papers, 2009.
23. Sekhon JS. Alternative balance metrics for bias reduction in matching methods for causal inference. Unpublished Papers for Download, 2007.
24. Rosenberger WF, Sverdlov O. Handling covariates in the design of clinical trials. Stat Sci. 2008 ; 23: 404-419
25. Agresti A Categorical data analysis. 2 nd edn. Hoboken, New Jersey: John Wiley & Sons, Inc., 2002. Hoboken, New Jersey: John Wiley & Sons, Inc. ; 2002
26. Hosmer DW, Lemeshow SS. Goodness-of-fit tests for the multiple logistic regression model. Commun Stat A-Theor. 1980 ; 9: 1043-1069
27. McFadden D Frontiers in econometrics. New York: Academic Press ; 1974
28. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. NEJM 1995; 333: 1581-1587.
29. Senn SJ. Testing for baseline balance in clinical trials. Stat Med. 1994 ; 13: 1715-1726
30. Roberts C, Torgerson DJ. Baseline imbalance in randomised controlled trials. Brit Medl J. 1999 ; 319: 185-185
31. Fayers P, King M. The baseline characteristics did not differ significantly. Qual Life Res. 2008 ; 17: 1047-1048
32. Rosner B Fundamentals of biostatistics. 6 th edn. Belmont, CA: Thomson Brooks/Cole, 2006. Belmont, CA: Thomson Brooks/Cole ; 2006
33. Ingall TJ, O'Fallon WM, Asplund K, Goldfrank LR, Hertzberg VS, Louis TA, et al. Findings from the reanalysis of the ninds tissue plasminogen activator for acute ischemic stroke treatment trial. Stroke. 2004 ; 35: 2418-2424
34. Frey JL. Recombinant tissue plasminogen activator (rtpa) for stroke: The perspective at 8 years. Neurologist. 2005 ; 11: 123-133
35. Hertzberg V, Ingall T, O'Fallon W, Asplund K, Goldfrank L, Louis T, et al. Methods and processes for the reanalysis of the ninds tissue plasminogen activator for acute ischemic stroke treatment trial. Clin Trials. 2008 ; 5: 308-315
36. ICH E9 Expert Working Group. Statisticl principles for clinical trials: ICH harmonized tripartite guideline. Stat Med 1999; 18: 1905-1942.
37. Trowman R, Dumville D, Torgerson DJ, Cranny G. The impact of trial baseline imbalances should be considered in systematic reviews: A methodological case study. J Clin Epidemiol. 2007 ; 60: 1229-1233
38. Raab G, Day S. How to select covariates to include in the analysis of a clinical trial. Control Clin Trials. 2000 ; 21: 330-342
39. Ford I, Norrie J. The role of covariates in estimating treatment effect and risk in long-term clincial trials. Stat Med. 2002 ; 21: 2899-2908